Amundi Simulations Plus, Inc. Transaction History
Amundi
- $275 Billion
- Q1 2025
A detailed history of Amundi transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Amundi holds 932 shares of SLP stock, worth $12,171. This represents 0.0% of its overall portfolio holdings.
Number of Shares
932
Previous 932
-0.0%
Holding current value
$12,171
Previous $25,000
12.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SLP
# of Institutions
173Shares Held
15.7MCall Options Held
2.6KPut Options Held
300-
Black Rock Inc. New York, NY2.46MShares$32.2 Million0.0% of portfolio
-
Conestoga Capital Advisors, LLC1.28MShares$16.7 Million0.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.1MShares$14.3 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X0896KShares$11.7 Million0.01% of portfolio
-
State Street Corp Boston, MA707KShares$9.23 Million0.0% of portfolio
About Simulations Plus, Inc.
- Ticker SLP
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 20,297,700
- Market Cap $265M
- Description
- Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...